NEUROMUSCULAR JUNCTIONS AS KEY CONTRIBUTORS AND THERAPEUTIC TARGETS IN SPINAL MUSCULAR ATROPHY
Spinal muscular atrophy (SMA) is a recessive autosomal neuromuscular disease, representing the most common fatal paediatric pathology. Even though, classically and in a simplistic way, it is categorized as a motor neuron (MN) disease, there is an increasing general consensus that its pathogenesis is...
Saved in:
Main Authors: | Marina eBoido (Author), Alessandro eVercelli (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment
by: Giovanna Menduti, et al.
Published: (2020) -
Gene therapy for spinal muscular atrophy: timing is key
by: Laurent Servais
Published: (2024) -
Spinal Muscular Atrophy
by: J Gordon Millichap
Published: (1990) -
Innovating spinal muscular atrophy models in the therapeutic era
by: Ilaria Signoria, et al.
Published: (2023) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
by: Melissa Bowerman, et al.
Published: (2017)